Rossano discussed unmet needs for patients with Danon disease and the potential of investigational gene therapy RP-A501.
Joseph Rossano, MD, MS, FAAP, FACC
Advertisement
Articles by Joseph Rossano, MD, MS, FAAP, FACC
Advertisement
Latest Updated Articles
Joseph Rossano, MD, on the Potential of Gene Therapy in Danon DiseasePublished: October 25th 2022 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
2
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
3
Assessing FDA-Approved CAR-T in Patients With Multiple Myeloma and Renal Failure
4
Hematology-Oncology Immunotherapy Highlights at ASH 2025
5
